|
1
|
Wei KR, Yu YL, Yang YY, Ji MF, Yu BH,
Liang ZH and Reng X: Epidemiological trends of nasopharyngeal
carcinoma in China. Asian Pac J Cancer Prev. 11:29–32.
2010.PubMed/NCBI
|
|
2
|
Zhou G, Zhai Y, Cui Y, Zhang X, Dong X,
Yang H, He Y, Yao K, Zhang H, Zhi L, et al: MDM2 promoter SNP309 is
associated with risk of occurrence and advanced lymph node
metastasis of nasopharyngeal carcinoma in Chinese population. Clin
Cancer Res. 13:2627–2633. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li Y, Fu L, Wong AM, Fan YH, Li MX, Bei
JX, Jia WH, Zeng YX, Chan D, Cheung KM, et al: Identification of
genes with allelic imbalance on 6p associated with nasopharyngeal
carcinoma in southern Chinese. PLoS One. 6:e145622011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Xiao M, Zhang L, Zhu X, Huang J, Jiang H,
Hu S and Liu Y: Genetic polymorphisms of MDM2 and TP53 genes are
associated with risk of nasopharyngeal carcinoma in a Chinese
population. BMC Cancer. 10:1472010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yu H, Huang YJ, Liu Z, Wang LE, Li G,
Sturgis EM, Johnson DG and Wei Q: Effects of MDM2 promoter
polymorphisms and p53 codon 72 polymorphism on risk and age at
onset of squamous cell carcinoma of the head and neck. Mol
Carcinog. 50:697–706. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Markey MP: Regulation of MDM4. Front
Biosci. 16:1144–1156. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yu H, Wang LE, Liu Z, Wei S, Li G, Sturgis
EM and Wei Q: Polymorphisms of MDM4 and risk of squamous cell
carcinoma of the head and neck. Pharmacogenet Genomics. 21:388–396.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kulkarni DA, Vazquez A, Haffty BG, Bandera
EV, Hu W, Sun YY, Toppmeyer DL, Levine AJ and Hirshfield KM: A
polymorphic variant in human MDM4 associates with accelerated age
of onset of estrogen receptor negative breast cancer.
Carcinogenesis. 30:1910–1915. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fang S, Krahe R, Lozano G, Han Y, Chen W,
Post SM, Zhang B, Wilson CD, Bachinski LL, Strong LC and Amos CI:
Effects of MDM2, MDM4 and TP53 codon 72 polymorphisms on cancer
risk in a cohort study of carriers of TP53 germline mutations. PLoS
One. 5:e108132010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Huang SF, Chen IH, Liao CT, Wang HM, Liou
SH and Hsieh LL: Combined effects of MDM2 SNP 309 and p53 mutation
on oral squamous cell carcinomas associated with areca quid
chewing. Oral Oncol. 45:16–22. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Toledo F and Wahl GM: MDM2 and MDM4: p53
regulators as targets in anticancer therapy. Int J Biochem Cell
Biol. 39:1476–1482. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ménendez S, Goh AM, Camus S, Ng KW, Kua N,
Badal V and Lane DP: MDM4 downregulates p53 transcriptional
activity and response to stress during differentiation. Cell Cycle.
10:1100–1108. 2011.PubMed/NCBI
|
|
13
|
Mancini F, Gentiletti F, D’Angelo M,
Giglio S, Nanni S, D’Angelo C, Farsetti A, Citro G, Sacchi A,
Pontecorvi A and Moretti F: MDM4 (MDMX) overexpression enhances
stabilization of stress-induced p53 and promotes apoptosis. J Biol
Chem. 279:8169–8180. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Atwal GS, Kirchhoff T, Bond EE, Montagna
M, Menin C, Bertorelle R, Scaini MC, Bartel F, Bohnke A, Pempe C,
et al: Altered tumor formation and evolutionary selection of
genetic variants in the human MDM4 oncogene. Proc Natl Acad Sci
USA. 106:10236–10241. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nichols HB, Trentham-Dietz A, Hampton JM,
Titus-Ernstoff L, Egan KM, Willett WC and Newcomb PA: From menarche
to menopause: trends among US Women born from 1912 to 1969. Am J
Epidemiol. 164:1003–1011. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chang ET and Adami HO: The enigmatic
epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol
Biomarkers Prev. 15:1765–1777. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tse KP, Su WH, Yang ML, Cheng HY, Tsang
NM, Chang KP, Hao SP, Yao SY and Chang YS: A gender-specific
association of CNV at 6p21.3 with NPC susceptibility. Hum Mol
Genet. 20:2889–2896. 2011. View Article : Google Scholar
|
|
18
|
Suda T, Yoshihara M, Nakamura Y, Sekiguchi
H, Godai TI, Sugano N, Tsuchida K, Shiozawa M, Sakuma Y, Tsuchiya
E, et al: Rare MDM4 gene amplification in colorectal cancer: The
principle of a mutually exclusive relationship between MDM
alteration and TP53 inactivation is not applicable. Oncol Rep.
26:49–54. 2011.PubMed/NCBI
|
